Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 111.96 USD 1.19%
Market Cap: 22.3B USD
Have any thoughts about
Zimmer Biomet Holdings Inc?
Write Note

Zimmer Biomet Holdings Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zimmer Biomet Holdings Inc
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Zimmer Biomet Holdings Inc
NYSE:ZBH
Net Issuance of Common Stock
-$1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-17%
Becton Dickinson and Co
NYSE:BDX
Net Issuance of Common Stock
-$500m
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
-2%
Boston Scientific Corp
NYSE:BSX
Net Issuance of Common Stock
$219m
CAGR 3-Years
N/A
CAGR 5-Years
13%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Net Issuance of Common Stock
-$253m
CAGR 3-Years
42%
CAGR 5-Years
-100%
CAGR 10-Years
17%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Issuance of Common Stock
$345.3m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zimmer Biomet Holdings Inc
Glance View

Market Cap
22.3B USD
Industry
Health Care
Economic Moat
None

Zimmer Biomet Holdings Inc. is a leading global medical device company renowned for its innovative solutions in the musculoskeletal health sector. Founded in 1927 and headquartered in Warsaw, Indiana, the company specializes in orthopedic implants, including those used in joint reconstruction and spinal surgery, as well as dental and neuromuscular devices. With a commitment to enhancing the quality of life for patients worldwide, Zimmer Biomet leverages cutting-edge technology and extensive research to develop products that cater to an aging population and a growing demand for minimally invasive surgical options. As the healthcare landscape evolves, Zimmer Biomet’s adaptable business strategy and focus on strategic partnerships position it favorably to capture new market opportunities and drive future growth. For investors, Zimmer Biomet represents a compelling choice within the healthcare sector due to its strong market presence and consistent revenue generation. The company operates in a resilient industry characterized by ongoing technological advancements and a steady demand for orthopedic procedures driven by demographic trends. Zimmer Biomet has strategically streamlined its operations, enhancing operational efficiencies and reducing costs, which are promising signs of financial health. With a robust pipeline of innovative products and a focus on expanding its global footprint, Zimmer Biomet is well-equipped to navigate the complexities of the healthcare market and deliver sustainable value to its shareholders over the long term.

ZBH Intrinsic Value
154.4 USD
Undervaluation 27%
Intrinsic Value
Price

See Also

What is Zimmer Biomet Holdings Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
-1.1B USD

Based on the financial report for Sep 30, 2024, Zimmer Biomet Holdings Inc's Net Issuance of Common Stock amounts to -1.1B USD.

What is Zimmer Biomet Holdings Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
-17%

Over the last year, the Net Issuance of Common Stock growth was -255%.

Back to Top